Fifteen patients with acute myocardial infarction and an elevated pulmonary capillary wedge pressure were given 40 mg furosemide intravenously within 24 hr of diagnosis of infarction. We divided the patients into two groups on the basis of the diuretic response to furosemide: nine who responded with a diuresis of greater than 400 ml in two hours, and six with a lower diuresis. Circulation, Volume XLVIII, September 1973 in the absence of cardiogenic shock.2-5 The purpose of the present study is to determine the effectiveness and role of intravenous furosemide in the therapy of patients with elevated left ventricular filling pressure following acute myocardial infarction.
HEMODYNAMIC MEASUREMENTS in pa-
tients with acute myocardial infarction and left ventricular dysfunction have allowed an objective assessment of the efficacy of drug therapy. Digitalis given within the first 24 hours of acute myocardial infarction is often ineffective in lowering left ventricular filling pressure and improving left ventricular pump function.' Because of this, furosemide and other diuretic agents have been used as the primary therapy for congestive heart failure associated with acute myocardial infarction From the Johns Hopkins University School of Medicine, Baltimore, Maryland. in the absence of cardiogenic shock.2-5 The purpose of the present study is to determine the effectiveness and role of intravenous furosemide in the therapy of patients with elevated left ventricular filling pressure following acute myocardial infarction.
Methods
Fifteen patients with acute transmural myocardial infarction and a pulmonary capillary wedge pressure of greater than 15 mm Hg were studied. All patients had a transmural myocardial infarction documented by serial electrocardiographic changes, including a Q wave of at least 0.04 sec in duration and 3 mm in voltage, as well as a rise in serum creatine phosphokinase (CPK), serum glutamic oxaloacetic transaminase (SGOT), and lactic dehydrogenase (LDH) (> 50, > 19, > 300 International units, respectively). The mean time of study from onset of chest pain was 15 hr. All of the patients except one had one or more signs of congestive heart failure, including pulmonary rales, an S-3 gallop, jugular venous distension, tachycardia, and X-ray evidence of pulmonary congestion. The clinical characteristics of the patients are shown in table 1. tricular failure, and five of six were in Class III compared to one of nine of the responders. They had a significantly increased serum urea nitrogen (SUN) of 25 compared to 18 in the responders (P < 0.001). Significant differences in initial hemodynamic parameters between responders and nonresponders were found for arterial venous oxygen (AVO2) difference (P < 0.01) and pulmonary capillary wedge pressure (P < 0.05). Five of the six nonresponders died (83%) while none of the nine responders died (P < 0.01).
Twenty minutes following the administration of intravenous furosemide the responders showed a significant fall in pulmonary capillary wedge pressure of 20% (P < 0.01) accompanied by a small but significant decrease in cardiac index and an increase in systemic vascular resistance index (P < 0.001). At the end of the two hour study period, pulmonary capillary wedge pressure had fallen significantly (P < 0.01), 35% from control, while cardiac index and systemic vascular resistance index had returned toward control values (not significant) and mean arterial pressure was reduced by 10% (P < 0.01). While pulmonary congestion was reduced in the responders following administration of furosemide, there was no apparent increase in left ventricular function as shown by the relationship between left ventricular filling pressure (pulmonary capillary wedge pressure) and stroke work index ( fig. 3) .
Discussion
On the basis of the diuretic response to 40 mg of intravenous furosemide, we were able to divide the 15 patients in the present study into two groups; responders and nonresponders. All the patients had an elevated pulmonary capillary wedge pressure suggesting an elevated left ventricular filling pressure. Although most of the patients had the physical signs associated with left ventricular failure, namely an S-3 gallop, moist pulmonary rales, and tachycardia as well as X-ray evidence of pulmonary congestion, we have found, as have Lassers et al.,7 that the correlation between clinical signs and hemodynamic findings is often poor. A raised pulmonary capillary wedge pressure may precede physical signs of congestive heart failure, and conversely, the physical signs of failure may persist for a considerable period after the pulmonary capillary wedge pressure has returned to normal. While the patients in the present study had an elevated left ventricular filling pressure and varying degrees of pulmonary congestion, this combination does not necessarily indicate true congestive heart failure but may be due to a decreased myocardial compliance with secondary pulmonary congestion.8
The therapeutic effect of intravenous furosemide would, in the nine responding patients, appear to be a beneficial one; left ventricular filling pressure fell, relieving pulmonary congestion. This, in combination with a slight but significant decrease in arterial pressure, would result in a decrease in myocardial wall stress, and therefore myocardial oxygen requirements, two hours after furosemide. Agents which reduce myocardial oxygen requirements have been shown to reduce experimental infarct size.9 However, while pulmonary congestion was relieved, it should be pointed out that left Circulation, Volume XLVIII, September 1973 ventricular pump function did not improve, as shown by the relationship between left ventricular filling pressure, pulmonary capillary wedge pressure, and stroke work index ( fig. 3) . The finding of a large fall in cardiac output and systemic pressure ( fig. 1 ) in occasional patients with acute myocardial infarction following a 40 mg intravenous dose of furosemide suggests that this dosage is potentially harmful and should be used with caution. In most patients an initial 20 mg dose may suffice. If the diuretic response to an initial 20 mg intravenous dose is inadequate, additional increments can then be given.
There are relatively few reported studies in which an intravenous diuretic has been used as the primary therapy in pulmonary congestion associat- reported a patient with pulmonary edema who responded rapidly, without an accompanying diuresis, and suggested that the fluid was removed from the pulmonary circulation prior to the onset of diuresis.10 Bhaitia, Singh, and Manchanda, in studying the effects of intravenous furosemide in patients recovering from high altitude pulmonary edema, also found that pulmonary blood volume decreased within 15 min of administration of furosemide, well before the onset of diuresis.1" Recently, Dikshit et al. have shown that the reduction in pulmonary congestion in patients with acute myocardial infarction following administration of intravenous furosemide occurred before the onset of diuresis and was secondary to peripheral venous pooling.4 Peripheral venous pooling was not looked for in the present study, but we also noted a fall in pulmonary capillary wedge pressure before the onset of diuresis. While the primary effect of furosemide appears to be a reduction of pulmonary vascular volume through a decrease in venous return, our data and that of others would suggest that there is a reduction in systemic vascular volume as manifested by a fall in the cardiac index and systemic pressure. In some patients this may result in severe hypotension necessitating volume replacement ( fig. 1 ).
The identification of the nonresponder group was of prognostic importance in that only one of the six patients survived, and this patient has had persistent congestive heart failure. The failure to respond to an initial 40 mg intravenous dose of furosemide suggests that these patients had inadequate systemic and renal perfusion. This was confirmed by the finding of a significantly wider arterial venous (AV) oxygen difference and higher SUN than in the responders. The nonresponders also failed to respond to high doses of intravenous furosemide (up to 300 mg), digitalis, and inotropic agents. It should be pointed out that even if they did respond to higher doses, in the range of 1000 mg, this may not have altered their survival, since although pulmonary congestion was relieved in the responders, left ventricular pump function did not improve ( fig. 3 ). The ideal agent for patients with severe left ventricular dysfunction associated with acute myocardial infarction such as our nonresponding group would be one which produced relief of pulmonary congestion along with an increase in left ventricular pump function, without a significant increase in myocardial oxygen requirements. Although furosemide may be of value as a secondary agent in these patients, it cannot be recommended as the primary therapeutic agent in patients with severe left ventricular dysfunction associated with acute myocardial infarction. The failure to respond to the initial 40 mg dose of intravenous furosemide should, however, indicate the need for careful hemodynamic monitoring and more intense therapeut:c efforts because of the high mortality found in this group in the present study.
